tremelimumab,durvalumab,Sorafenib
AstraZeneca,Pfizer
['sorafenib', 'tislelizumab', 'ca,022,i', 'ca,022,1', 'hcc', 'arca, (-arcade)']
fantastic #hcc session at #wcgic2023 in barcelona chaired by and with new data, educational lectures, and clinical case discussion 
Associate Professor of Medical Oncology at HUNIMED, GI cancer specialist with research interest in #livercancer, #HCC, #biliarytractcancer, #cholangiocarcinoma